Sarasota, FL, Nov. 23, 2016 (GLOBE NEWSWIRE) -- Zion Research has published a new report titled “Endocrine Testing Market (Dehydroepiandrosterone Sulfate, Progesterone, Luteinizing Hormone, Estradiol, Human Chorionic Gonadotropin, Follicle Stimulating, Testosterone, Thyroid Prolactin, Thyroid Stimulating Hormone, Cortisol, Insulin, and Other Tests) By Technology (Monoclonal & Polyclonal Antibody Technologies, Tandem Mass Spectrometry, Immunoassay, Clinical Chemistry Technologies, and Others) for End-use Commercial Laboratories, Home-Based Tests, Ambulatory Care Centers, Hospitals and Other End-users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021” . According to the report, the global endocrine testing market was valued at around USD 7.00 billion in 2015 and is expected to reach approximately USD 10.50 billion by 2021, growing at a CAGR of around 8.5% between 2016 and 2021.
The endocrine system is a family of glands and organs in the human body. The endocrine system consists of various glands in different parts of the body that secrete hormones directly into the blood. An optimally functioning endocrine system is essential to restoring and maintaining good health. Endocrinology blood tests to identify hormone imbalances and abnormal gland function.
The endocrine testing market is expected to exhibit exponential growth in the coming years. The market is mainly driven by increasing geriatric, diabetic, and obese population worldwide. Moreover, increasing health awareness coupled with the government initiatives has facilitated early diagnosis of endocrine disorders, which is expected to drive the market growth in the near future. Additionally, the changing lifestyles, growing stress levels, and unhealthy food habits have resulted in increased incidences of obesity and disturbed hormonal levels, which has contributed substantially towards the growth of the endocrine diagnostics market. On the other hand, the high cost of technology may hamper the market growth during the forecast period.
Browse through 18 Market Tables and 26 Figures spread over 110 Pages and in-depth TOC on “Global Endocrine Testing Market: Test, Technology, End-User, Size, Share, Industry Analysis and Forecast 2015-2021”.
Request free Sample copy of Endocrine Testing Market Report @ https://www.zionmarketresearch.com/sample/end...ing-market
Nonetheless, investment in research and technology is considered as a major opportunity for the growth of the global endocrine testing market.
On the basis of test, the market can be segmented into Dehydroepiandrosterone sulfate (DHEAS), Progesterone, Luteinizing Hormone (LH), Estradiol (E2), Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH), testosterone, thyroid prolactin, Thyroid Stimulating Hormone (TSH), cortisol, insulin, and other tests such as gastrin, thymosin, and secretin tests. In 2015, thyroid stimulating hormone (TSH) accounted for the largest market share in terms of revenue. This growth is mainly due to rise incidences of thyroid disorders and the growing awareness about the correlation between variations in the thyroid hormones levels and cardiovascular disorders. Insulin test was another key outlet of the market and is expected to show witness fastest growth in the near future.
The market is segmented on the basis of technology into monoclonal & polyclonal antibody technologies, tandem mass spectrometry, immunoassay, sensors, clinical chemistry technologies, and others. Tandem mass spectrometry held the largest share of total revenue generated in 2015. Mass spectroscopy analysis is the most recent developed technology. The sensitivity of the tests using mass spectroscopy is very high.
Browse the full " Endocrine Testing Market (Dehydroepiandrosterone Sulfate, Progesterone, Luteinizing Hormone, Estradiol, Human Chorionic Gonadotropin, Follicle Stimulating, Testosterone, Thyroid Prolactin, Thyroid Stimulating Hormone, Cortisol, Insulin, and Other Tests) By Technology (Monoclonal & Polyclonal Antibody Technologies, Tandem Mass Spectrometry, Immunoassay, Clinical Chemistry Technologies, and Others) for End-use Commercial Laboratories, Home-Based Tests, Ambulatory Care Centers, Hospitals and Other End-users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021 " report at https://www.zionmarketresearch.com/report/end...ing-market
The market based on end-use is classified into commercial laboratories, home-based tests, ambulatory care centers, hospitals and other healthcare settings. The commercial laboratories held the significant share in terms of revenue. This growth is attributed to advanced infrastructure coupled with skilled personnel. The home-based test segment is growing fast with the introduction of new user-friendly and cost-effective diagnostic kits. This is expected to increase the penetration of home-based tests.
North America is currently leading the sector in the endocrine testing market with a share of over 35.0% with respect to revenue generation in 2015. Key factors such as the presence of well-developed healthcare system and rising investment in research and development have contributed to the large share of the endocrine testing market in North America. Notably, the U.S. is expected to exhibit considerable growth primarily due to rising R&D endeavors.
Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/en...ing-market
Asia-Pacific is projected to be the fastest growing regional market in the near future. Asia-Pacific is expected to overtake Europe, in terms of market share, by 2021 mainly owing to the growing awareness regarding benefits of the digital signage. Unmet requirements and the developing healthcare sector attributed towards market growth in Asia Pacific. Furthermore, the endocrine testing market has the huge opportunity in the emerging markets of Asia Pacific due to the increasing aging population, rising health awareness about endocrine disorders and increasing investment in the healthcare sector especially in China and India.
Europe is expected to exhibit significant growth in the years to come. The growth is mainly due to increase concern regarding health among people. Moreover, increasing demand endocrine testing kits coupled with technological advancement is expected to fuel the market growth within the forecast period.
Request a customize report @ https://www.zionmarketresearch.com/custom/385
The Middle East & Africa is expected to witness significant growth in the near future. This growth is mainly due to the increasing healthcare awareness coupled with advancement in technology. Latin America is another important regional market and is expected to experience noticeable growth over the forecast period. This growth is mainly attributed to favorable government funding and increasing health awareness. Thus, all aforementioned parameters are expected to propel the market growth in this region.
Some of the key players include Bio Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., LabCorp, and Quest Diagnostics, Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies, bioMerieux SA.
Purchase a direct copy of report with TOC @ https://www.zionmarketresearch.com/buynow/su/...ing-market
This report segments the global endocrine testing market as follows:
Global Endocrine Testing Market: Test Segment Analysis
- Dehydroepiandrosterone sulfate (DHEAS)
- Progesterone
- Luteinizing Hormone (LH)
- Estradiol (E2)
Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH)
- Testosterone
- Thyroid prolactin
- Thyroid Stimulating Hormone (TSH), cortisol, insulin
- Other Tests
Global Endocrine Testing Market: Technology Segment Analysis
- Monoclonal & Polyclonal Antibody Technologies
- Tandem Mass Spectrometry
- Immunoassay
- Sensors
- Clinical Chemistry Technologies
- Others
Global Endocrine Testing Market: End-user Segment Analysis
- Commercial Laboratories
- Home-Based Tests
- Ambulatory Care Centers
- Hospitals
- Other Healthcare Settings
Global Endocrine Testing Market: Regional Segment Analysis
- North America
- Europe
- Asia Pacific
- Latin America
- The Middle East and Africa
Related Reports:
- Diabetes Care Devices Market: https://www.zionmarketresearch.com/report/dia...ces-market
- Injectable Drug Delivery Market: https://www.zionmarketresearch.com/report/inj...ery-market
- Catheter Market: https://www.zionmarketresearch.com/report/catheter-market
- Vascular Stents Market: https://www.zionmarketresearch.com/report/vas...nts-market
- Ultrasound Devices Market: https://www.zionmarketresearch.com/report/ult...ces-market
- Retinal Surgery Devices Market: https://www.zionmarketresearch.com/report/ret...ces-market
- Implantable Drug Delivery Devices Market: https://www.zionmarketresearch.com/report/imp...ces-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Contact Us: Joel John 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com/
